CLAIM CARD
`fact_id=166319` (`A_core`) — Metformin (0.1%) combined with rapamycin (14 ppm) robustly extended lifespan, suggestive of an added benefit. doi=10.1111/acel.12496
Evidence grade: exploratory
Contradiction status: none
Publication: 48abac66-87ee-46dd-a1e0-1a1bbcc8d12d
Provenance: Derivation Web chain
Citation Support
source_1Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restrictionsource_2Rapamycin fed late in life extends lifespan in genetically heterogeneous micesource_3Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducersource_4Transient rapamycin treatment can increase lifespan and healthspan in middle-aged micesource_5Life-span Extension Drug Interventions Affect Adipose Tissue Inflammation in Aging